Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment. Clinics, [S. l.], v. 72, n. 4, p. 231–237, 2017. DOI: 10.6061/clinics/2017(04)07. Disponível em: https://www.revistas.usp.br/clinics/article/view/132851.. Acesso em: 1 may. 2024.